VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NRSN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NRSNNeuroSense Therapeutics Ltd.
$0.71$17M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNRSNQuarterly Financials

NeuroSense Therapeutics Ltd. (NRSN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

NeuroSense Therapeutics Ltd. (NRSN) quarterly income statement — complete revenue, gross profit & net income history

NRSN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q2'21Q1'21Q4'20Q3'20Q1'20
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses2.35M2.35M1.77M2.11M3.03M2.99M3.29M2.9M3.48M2.99M3.38M3.32M3.59M3.26M1.65M951K2.11M1.1M1.1M311K
OpEx % of Revenue--------------------
Selling, General & Admin1.09M1.09M685K946K1.46M1.11M1.33M1.27M1.57M1.14M1.83M1.61M1.72M1.97M1.6M453K92K138.5K138.5K58K
SG&A % of Revenue--------------------
Research & Development1.25M1.25M1.09M1.16M1.57M1.88M1.96M1.63M1.91M1.85M1.54M1.71M1.87M1.3M46K498K2.02M980.5K980.5K267K
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-2.35M-2.35M-1.77M-2.11M-3.03M-2.99M-3.29M-2.9M-3.48M-2.99M-3.38M-3.32M-3.59M-3.26M-1.65M-951K-2.11M-1.12M-1.12M-325K
Operating Margin %--------------------
Operating Income Growth %22.57%21.64%46.12%27.27%12.86%-0.1%2.72%12.71%3.15%8.36%-105.41%--277.5%-54.62%-47.01%--549.54%---
EBITDA-2.34M-2.34M-1.77M-2.1M-3.02M-2.99M-3.28M2.99M-3.45M-2.99M-3.2M-3.32M-3.57M-3.26M-1.64M-950.25K-2.11M-1.12M00
EBITDA Margin %--------------------
EBITDA Growth %22.57%21.64%46.2%-170.39%12.42%-0.03%-2.46%189.99%3.25%8.43%-94.8%--275.64%-54.64%-47.04%-----
D&A (Non-Cash Add-back)4K4K5.5K5.25K5.5K5.25K5.25K023.5K3K075020.5K7507507507507501.12M325K
EBIT-2.35M-2.35M-1.77M-2.11M-857K-2.99M-5.15M2.99M-5.53M-2.61M-3.2M-2.98M-3.45M-2.69M-1.65M-940K-2.11M-1.12M-1.12M-325K
Net Interest Income-8.5K-8.5K-30K-41K2.17M-2.41M-2.06M3.68M-276K-243K206K325K109K549K-1.16M11K-13K000
Interest Income00002.17M0-3.72M3.69M067K206K335K144K572K011K0000
Interest Expense8.5K8.5K30K41K02.41M-1.66M12K276K310K010K35K23K1.16M013K000
Other Income/Expense-8.5K-8.5K-30K-41K2.17M-2.41M337K3.68M-1.75M67K229K325K109K549K1.54M23K-13K16K16K14K
Pretax Income-2.35M-2.35M-1.8M-2.15M-857K-5.4M-2.95M784K-5.22M-2.92M-3.15M-2.99M-3.48M-2.71M-101K-928K-2.12M-1.1M-1.1M-311K
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-2.35M-2.35M-1.8M-2.15M-857K-5.4M-2.95M784K-5.22M-2.92M-3.15M-2.99M-3.48M-2.71M-101K-928K-2.12M-1.1M-1.1M-311K
Net Margin %--------------------
Net Income Growth %-174.74%56.43%38.95%-373.98%83.6%-84.82%6.35%126.19%-50.1%-7.7%-3018.81%--275.11%-27.82%90.84%--582.96%---
Net Income (Continuing)-2.35M-2.35M-1.8M-2.15M-857K-5.4M-2.95M784K-5.22M-2.92M-3.15M-2.99M-3.48M-2.71M-101K-928K-2.12M-1.1M-1.1M-311K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.09-0.09-0.08-0.11-0.05-0.35-0.190.06-0.38-0.25-0.25-0.23-0.30-0.24-0.01-0.08-0.19-0.20-0.20-0.06
EPS Growth %-95.16%73.51%56.21%-291.3%87.5%-40%24%125%-26.67%-4.17%---253.77%-26.32%95.4%--233.33%---
EPS (Basic)-0.09-0.09-0.08-0.11-0.05-0.35-0.190.06-0.38-0.25-0.25-0.23-0.30-0.24-0.01-0.08-0.19-0.20-0.20-0.06
Diluted Shares Outstanding25.4M25.4M21.65M19.81M18.05M15.4M15.38M13.62M13.62M11.79M11.78M11.59M11.6M11.31M10.94M10.94M5.58M5.58M5.58M5.45M
Basic Shares Outstanding25.4M25.4M21.65M19.81M18.05M15.4M15.38M13.62M13.62M11.79M11.78M11.59M11.6M11.31M10.94M10.94M5.58M5.58M5.58M5.45M
Dividend Payout Ratio--------------------